<DOC>
	<DOCNO>NCT00034294</DOCNO>
	<brief_summary>Approximately 300 patient enter study take place throughout United States , Canada United Kingdom . This study aim determine investigational drug safe effective treating symptom C. difficile-associated diarrhea lower risk repeat episode diarrhea . The investigational drug evaluate comparison current standard antibiotic treatment , patient receive active medication . All study-related care provide include doctor visit , physical exam , laboratory test study medication . Total length participation approximately 10 week .</brief_summary>
	<brief_title>A Study GT160-246 Versus Vancomycin Patients With Clostridium Difficile-Associated Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<mesh_term>Enterocolitis , Pseudomembranous</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Be least 18 year old . Have active mild moderate C. difficile Associated Diarrhea ( CDAD ) . Be able tolerate oral medication . Not pregnant breastfeeding . Sign date inform consent form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>C. difficile-associated diarrhea</keyword>
	<keyword>CDAD</keyword>
	<keyword>Clostridium difficile-Associated Diarrhea</keyword>
	<keyword>Clostridium enterocolitis</keyword>
	<keyword>antibiotic-associated diarrhea</keyword>
	<keyword>clostridium difficile colitis</keyword>
	<keyword>infectious diarrhea</keyword>
	<keyword>chronic diarrhea</keyword>
	<keyword>antibiotic-associated colitis</keyword>
</DOC>